The proposed bill would amend current statutes to allow assisted living homes and centers to offer mild hyperbaric oxygen therapy (HBOT) to residents. Specifically, it would insert provisions that require the use of a Class II mild hyperbaric oxygen chamber registered with the FDA, which must be prescribed by a physician. The bill also mandates that a trained staff member be present whenever a resident receives HBOT and that residents be informed of the therapy's risks and contraindications, as well as the necessity of consulting their treating physician regarding personal health risks.

Additionally, the bill would prohibit assisted living facilities from providing HBOT to residents requiring directed care services unless it is ordered by the resident's physician and informed consent is obtained. The Department of Health Services would be granted the authority to adopt necessary rules for the implementation of these provisions. Overall, the bill aims to establish clear guidelines and safety measures for the administration of mild HBOT in assisted living settings.

Statutes affected:
Introduced Version: 36-420.06
Senate Engrossed Version: 36-420.06